Liping Tan
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study.
Journal: Frontiers in molecular biosciences
Published: February 14, 2026
Green Fabrication of Zinc-Based Metal-Organic Frameworks@Bacterial Cellulose Aerogels via In Situ Mineralization for Wastewater Treatment.
Journal: Molecules (Basel, Switzerland)
Published: January 19, 2025
Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial.
Journal: Signal transduction and targeted therapy
Published: September 13, 2024
A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: August 28, 2024
Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
Journal: International immunopharmacology
Published: January 15, 2024
Prognostic Significance of Pretreatment Plasma D-dimer Levels in EGFR-Positive Advanced Non-Small Cell Lung Cancer Patients Receiving Osimertinib: A Multicentre Retrospective Study.
Journal: International journal of general medicine
Published: September 01, 2023
PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study.
Journal: Frontiers in immunology
Published: October 02, 2022
The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis.
Journal: The Journal of international medical research
Published: April 07, 2021
Pretreatment plasma d-dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer.
Journal: The Journal of international medical research
Published: October 26, 2020
A Retrospective Cohort Study on Pretreated Neutrophil-to-Lymphocyte Ratio and Prognosis of Small Cell Lung Cancer: Evidence of Effect Modification by Chemotherapy Regimen.
Journal: Cancer management and research
Published: May 21, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026